Advertisements

Vasocard (Amlodipine)

Quick links to important sections

Vasocard (Amlodipine)

Advertisements

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Vasocard (Amlodipine)

Property Description
Active ingredient Amlodipine (as Amlodipine besylate)
Form Oral Tablet
Pharmacological class Calcium Channel Blocker (CCB)
Common purpose Circulatory management (Antihypertensive/Antianginal)
Origin Synthetic Compound (Dihydropyridine)

Amlodipine as a Dihydropyridine Calcium Channel Blocker

Vasocard is a brand name for the prescription-only substance Amlodipine, which is defined by its role as a Calcium Channel Blocker (CCB). Amlodipine is a synthetic compound and belongs specifically to the dihydropyridine group of CCBs. This classification is significant as it indicates a drug that primarily acts on the muscle cells in the walls of the blood vessels, rather than the heart’s electrical system. Dihydropyridine CCBs function by promoting the widening of blood vessels. Amlodipine is clinically recognized for its efficacy and is frequently a first-line agent for the long-term management of high blood pressure, a typical use scenario where sustained action is crucial.


Composition and General Therapeutic Purpose

The active component in the medicine is Amlodipine, supplied as the salt Amlodipine besylate, and it is formulated as a single-ingredient oral tablet. This preparation ensures that the therapeutic effects are derived solely from the amlodipine compound, a distinguishing feature from combination formulations that integrate a secondary drug. The fundamental purpose of Amlodipine is to regulate blood pressure and improve systemic blood flow. Its mechanism involves L-type calcium channel antagonism, which eases tension in the arterial walls. Amlodipine provides a sustained reduction in peripheral vascular resistance. The resulting effect broadly classifies the medicine as an effective antihypertensive agent and an antianginal agent for circulatory management.

Regulatory References

  1. MedlinePlus Drug Information
Advertisements

What side effects are possible with Vasocard (Amlodipine)?

Official Adverse Reactions and Safety Profile

The safety profile for Amlodipine (Vasocard) is classified by regulatory agencies based on frequency and the body systems affected. This information is derived from clinical trials and post-marketing surveillance data.


Frequency-Classified Adverse Reactions

The most frequently documented adverse reactions, classified as Common (affecting 1 to 10 in 100 people), include edema (swelling, particularly of the ankles or feet), headache, fatigue, dizziness, and flushing. Other common effects include somnolence, nausea, abdominal pain, and palpitations.

Reactions classified as Uncommon (affecting 1 to 10 in 1,000 people) involve systems such as the Gastrointestinal (e.g., dry mouth, vomiting), Nervous (e.g., tremor, syncope), and Skin (e.g., rash, pruritus) systems. Rare and Very Rare effects include conditions such as confusion (Rare) and severe events like hepatitis, pancreatitis, angioedema, and serious dermatologic reactions like Stevens-Johnson syndrome (Very Rare).


Safety Patterns and Constraints

Official regulatory documents note that some adverse reactions are associated with the start of therapy, such as headache and somnolence. Edema is cited as an effect that may occur in a dose-related manner.

Specific safety considerations exist for certain populations. Clearance of Amlodipine is decreased in patients with hepatic impairment, necessitating careful attention. Caution is also noted for use in older adults due to increased clearance time, and in patients with severe heart failure.

Safety restrictions are documented for individuals with conditions such as severe hypotension, cardiogenic shock, or significant outflow tract obstruction like high-grade aortic stenosis.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official overdose profile for Amlodipine is defined by its pronounced cardiovascular effects. A massive overdose primarily results in excessive peripheral vasodilation leading to severe or marked hypotension (extremely low blood pressure). Other documented clinical manifestations include rapid heartbeat (tachycardia), dizziness, and fainting. Overdose can rapidly lead to life-threatening outcomes that require immediate medical attention.

The regulatory guidance specifies that emergency services (911) must be called immediately if the affected person shows signs of collapse, a seizure, trouble breathing, or unconsciousness (cannot be awakened). Otherwise, the Poison Help Line should be contacted for urgent guidance.

Management of an Amlodipine overdose is strictly symptomatic and supportive. Due to the drug's properties, no specific antidote is known to counteract the effects. Essential procedural steps documented in regulatory guidance include initiating active cardiac and respiratory monitoring and ensuring frequent blood pressure measurements to manage hypotension. Treatment involves cardiovascular support measures, including the elevation of extremities and the judicious administration of fluids and vasopressors, if necessary. Official documents note that hemodialysis is unlikely to be of benefit in managing the overdose.

Advertisements

Therapeutic Uses of Vasocard (Amlodipine)

What Vasocard (Amlodipine) Treats: Main Uses and Benefits

The primary role of Vasocard is generally to support the managing conditions associated with systemic imbalance by managing chronic circulatory conditions. The medication is used across three main therapeutic domains that provide supportive therapeutic benefit.

Vasocard is commonly used for the sustained, long-term control of hypertension (high blood pressure) and is applied as an antianginal agent to address recurrent chest discomfort and pain (angina pectoris), including both chronic stable and vasospastic types.

“This medication helps address symptoms related to physical discomfort and may assist in managing the frequency and severity of recurrent chest discomfort.”

By helping to stabilize and reduce persistent arterial pressure, the medication contributes to easing the overall symptom load and may assist in managing long-term cardiovascular risk factors. For patients with documented coronary artery disease (CAD), Amlodipine may be part of symptomatic management and is considered relevant in assisting with maintaining functional stability.


Quick Fact: Managing Conditions with Persistent Arterial Pressure

Amlodipine plays a role in managing symptoms related to heightened physiological activity by supporting the control of elevated arterial pressure, which supports general well-being during symptomatic phases.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Vasocard (Amlodipine)?

Population eligibility for Amlodipine is strictly defined by regulatory authorities and includes both absolute prohibitions and conditional use rules.

Contraindications and Prohibited Use

Amlodipine is contraindicated in patients with a known hypersensitivity to the drug, other dihydropyridine derivatives, or any of the inactive ingredients. It must not be used by individuals experiencing severe hypotension, shock (including cardiogenic shock), or those with obstruction of the left ventricular outflow tract (such as severe aortic stenosis).

Age-Related and Conditional Eligibility

Use is established for adults and for pediatric patients aged 6 to 17 years specifically for hypertension treatment. The safety and effectiveness in children under 6 years old are not established by regulators. For elderly patients, dosing should be initiated carefully or at the lower end of the range.

Restricted Use Populations

Patients with hepatic impairment require caution and slower dose titration due to the drug's prolonged clearance. Use during pregnancy is restricted and only recommended when the potential benefit outweighs the potential risk. Use during lactation is not recommended as the drug is known to be excreted in human milk. Patients with renal impairment are generally permitted to use Amlodipine without dose adjustment.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Amlodipine can interact with several other medications, primarily due to the way it is metabolized in the body by the CYP3A4 enzyme in the liver. Interactions typically result in either increased blood levels of amlodipine (increasing the risk of excessive blood pressure lowering) or increased blood levels of the co-administered drug (raising the risk of that drug’s side effects).

Key interactions include:

  • CYP3A4 Inhibitors: Strong and moderate inhibitors of this enzyme, such as certain antifungal medications (e.g., itraconazole, ketoconazole), some macrolide antibiotics (e.g., clarithromycin), or the calcium channel blocker diltiazem, can significantly increase amlodipine exposure. This may lead to an enhanced blood pressure-lowering effect and the risk of low blood pressure (hypotension).
  • Simvastatin: When taken with amlodipine, the blood level of the cholesterol-lowering medication simvastatin is substantially increased. To reduce the risk of muscle problems (myopathy), the dose of Simvastatin is recommended to be limited to 20 mg daily.
  • Immunosuppressants: Amlodipine can raise the blood levels of transplant medications, specifically Tacrolimus and Cyclosporine. When these drugs are used together, close monitoring of the immunosuppressant blood levels is required, and dose adjustments may be necessary.
  • Dantrolene (Infusion): The combined use of amlodipine and intravenous dantrolene carries a risk of severe hyperkalemia (high potassium) in susceptible patients.
  • Grapefruit Juice: Consumption of grapefruit or grapefruit juice is not advised, as it can increase amlodipine exposure in some individuals. Co-administration with other antihypertensive agents may result in an additive blood pressure reduction.
Advertisements

Mechanism of Action

The core mechanism of Amlodipine is the highly selective blockade of Voltage-dependent L-type Calcium Channels (Cav1.2) found primarily in the smooth muscle cells of the arteries and arterioles. This molecular action inhibits the influx of extracellular calcium ions ( Ca^2+), disrupting the Excitation-Contraction Coupling pathway and limiting muscle cell contraction.

The resulting vascular smooth muscle relaxation leads to widespread arterial vasodilation, a physiological event that decreases the total force the heart must pump against, known as Systemic Vascular Resistance (SVR) or Afterload. This mechanism also promotes coronary vasodilation, resulting in an increase in myocardial oxygen supply and a decrease in myocardial oxygen demand.

The molecule's slow association and dissociation rate with the L-type Ca^2+ channel receptor site correlates with the mechanism's long duration of action and contributes to its gradual physiological effect. A characteristic of this mechanism is its preferential action on arterioles over venules, which results in increased capillary hydrostatic pressure.

Advertisements

Dosage and Administration Information

Administration Guidelines for Vasocard (Amlodipine)

The usage of Amlodipine is characterized by a structured, long-term, continuous daily regimen, ensuring that dosage adjustments are gradual and response-driven.

Administration Scope

Feature Guideline
Route of administration Oral administration
Dosing schedule Adult Initial Dose: 5 mg once daily. Adult Maximum Dose: 10 mg once daily. Pediatric Dose (6–17 years): 2.5 mg to 5 mg once daily.
Timing in relation to meals (if applicable) May be taken with or without food.
Preparation requirements (if applicable) None required for the tablet form.
Age-group administration rules Older Adults/Hepatic Insufficiency: Lower initial dose of 2.5 mg once daily is implemented. Pediatric Patients: Doses exceeding 5 mg daily have not been evaluated and are restricted.
Missed-dose rules Skip the dose if it has been more than 12 hours since the scheduled time; do not double the dose.
Special procedural conditions Dosage titration (adjustment) should generally proceed over a 7 to 14-day interval tale.

Instruction Classifications (High-Level)

Classification Principle
Administration method type Oral administration of a single-ingredient tablet or equivalent form.
Frequency pattern Once daily, continuous use regimen.
Usage Framework Established protocols for clinical management.
Use-context constraints Dosage adjustments are contingent on allowing sufficient time (7–14 days) for the full pharmacologic response to be evaluated before change.

Resulting Procedural Structure

Step sequence:

  • The medicine is taken orally once every day.
  • Treatment is typically initiated at 5 mg daily for most adults.
  • Dose adjustments, when necessary, are made cautiously, usually separated by a minimum of one to two weeks.
  • Lower starting doses (2.5 mg) are implemented for older adults or those with hepatic impairment.
  • A missed dose should be skipped if the delay is significant, and the scheduled regimen is resumed without doubling the quantity.

Connection to the overall use protocol

The instructions establish a structured, long-term protocol for administration, beginning with an initial daily dose that may be escalated through slow, measured increments. The regimen specifies a once-daily oral intake that is independent of meal consumption, defining a flexible yet consistent schedule. These rules document the required time window for dose adjustment, ensuring that any change is made only after sufficient time has passed to evaluate the previous dose. The constraints also define a specialized lower starting dose for certain patient groups, standardizing the approach to initial treatment in these populations.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence Overview

Amlodipine, a third-generation dihydropyridine calcium channel blocker, has been extensively studied for the long-term management of hypertension (high blood pressure) and chronic stable angina or vasospastic angina.

Research suggests that the fundamental therapeutic action involves inhibiting the influx of calcium ions into the vascular smooth muscle cells and cardiac muscle cells. This process is associated with vasodilation, which may reduce the heart's workload and lower blood pressure.


Key Clinical Trial Findings

Landmark randomized controlled trials (RCTs) have consistently investigated amlodipine's long-term effect on cardiovascular health. These studies have focused on its role as a first-line agent in lowering blood pressure and reducing the risk of cardiovascular events, such as stroke and heart attack.

Area of Research Key Finding Focus Study Context
Cardiovascular Outcomes Whether use is associated with reduction in major adverse cardiovascular events (MACE). Long-term trials comparing amlodipine against other antihypertensive classes (e.g., ACE inhibitors).
Safety and Tolerability Examination of the drug's safety profile, particularly in complex patient populations. Meta-analyses and real-world studies assessing the risk of heart failure and other cardiovascular issues.
Angina Management Evaluation of the ability to increase exercise time and reduce the frequency of anginal attacks. Double-blind, placebo-controlled trials, often used in combination with beta-blockers.

Recent population-based and cohort studies have focused on clarifying earlier research questions regarding amlodipine's safety in patients with certain pre-existing cardiac conditions. These analyses generally support the continued use of amlodipine in the standard treatment of hypertension.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Vasocard (Amlodipine) (FAQ)


Q: Is Amlodipine considered a beta-blocker?

No. According to regulatory documentation, Amlodipine is classified as a dihydropyridine calcium channel blocker (CCB). This means it works by targeting the movement of calcium in the walls of blood vessels, which is a different pharmacological class from beta-blockers.


Q: Can Amlodipine be taken in the morning or evening?

Official dosage instructions state that Amlodipine should be taken once daily. Regulatory information does not specify a mandatory time of day (morning or evening), allowing for flexibility to establish a consistent daily dosing schedule.


Q: Is it normal to have swollen ankles when taking Amlodipine?

Official product information lists edema (swelling, especially in the ankles or feet) as a common adverse reaction reported in clinical trials. This indicates that the effect is frequently observed with the use of the medicine.


Q: What happens if I forget to take my Amlodipine dose one day?

Regulatory procedural guidance describes the process for a missed dose. If the delay is significant (e.g., more than 12 hours), the direction is to skip the missed dose and resume the normal schedule the following day, rather than taking a double dose.


Q: Does Amlodipine interact with grapefruit or grapefruit juice?

Official prescribing information describes grapefruit or grapefruit juice as generally restricted during use. This is because official documents indicate that grapefruit can affect a key enzyme in the body, potentially leading to increased exposure to Amlodipine.


Q: Can Amlodipine cause leg cramps or muscle pain?

Official safety documents list adverse events such as muscle cramps and myalgia (muscle pain) in post-marketing reports. These types of effects typically occurred in a very small percentage of patients in clinical trials.


Q: Can Amlodipine affect kidney function?

Official prescribing information states that for patients with renal impairment (kidney problems), no adjustment to the starting dose is typically needed. This suggests that the medicine is generally permitted for use without major dose changes based on kidney function.


Q: What should I do if I feel dizzy after taking Amlodipine?

Official documents list dizziness as a common adverse reaction. Regulatory safety information notes that the medicine may cause low blood pressure, and official documentation advises caution regarding potential symptomatic low blood pressure when changing positions.


Q: How long does Amlodipine stay in your system?

Amlodipine has a long terminal elimination half-life of approximately 30 to 50 hours, as noted in the official prescribing information. This long half-life is what supports the once-daily dosing schedule.


Q: Can people with liver problems use Amlodipine?

Use is permitted with caution in patients with hepatic impairment (liver problems). A lower starting dose and cautious dose adjustments are documented as necessary due to the drug's prolonged clearance in this population.


Q: Is it common for Amlodipine to cause a flushing sensation?

Yes, regulatory safety data lists flushing as a common adverse reaction. This indicates that the feeling of warmth or redness is a frequently observed effect associated with the use of the medicine.


Q: Does Amlodipine help prevent heart attacks?

Official regulatory text includes indications related to reducing the risk of fatal and nonfatal cardiovascular events, such as myocardial infarctions (heart attacks), when used as part of a regimen to manage high blood pressure. It is also indicated to reduce the risk of hospitalization for certain types of chest pain (angina).


Q: Why is my blood pressure still high even though I am taking Amlodipine?

Regulatory documents describe the medicine as having a gradual onset of effect. Official instructions specify that blood pressure effects are gradual, and dose adjustments are typically not considered until after 7 to 14 days of therapy at a given dose.


Q: Is Amlodipine used to treat heart failure?

Amlodipine is not officially indicated for the treatment of heart failure. Official labeling advises that caution is noted for its use in patients with certain forms of severe heart failure.


Q: How quickly should I expect Amlodipine to start working for blood pressure?

Regulatory documents describe the medicine as having a gradual onset of effect. Official documents state that peak concentrations are reached within 6 to 12 hours, and a steady level of the drug in the body is generally reached after approximately 7 to 8 days of consistent daily dosing.


Q: Does Amlodipine make you tired or cause fatigue?

Fatigue and somnolence (drowsiness) are listed as common adverse reactions in official prescribing information. This indicates that both effects were reported in a notable percentage of patients in clinical trials.


Q: Will Amlodipine help with anxiety related to high blood pressure?

Amlodipine is not indicated to treat anxiety. Official safety information lists anxiety as a psychiatric adverse reaction that occurred rarely (less than 1%) in clinical trials, suggesting a potential side effect rather than a benefit.


Q: Can Amlodipine make you gain weight?

Adverse event reports received after the medicine was released to the market have included instances of both weight increase (weight gain) and weight decrease. These events are noted as generally rare.


Q: Is it okay to take Amlodipine with other blood pressure medicines?

Yes. Official regulatory indications state that Amlodipine may be used alone or in combination with other antihypertensive agents for the management of high blood pressure.


Q: Are there any specific vitamins or supplements that interact with Amlodipine?

Specific interactions are detailed for certain drugs, such as strong CYP3A4 inhibitors. Official patient counseling information includes the statement that patients should report all medications, including any vitamins, supplements, or herbal products.


Q: What kind of research exists on long-term use of Amlodipine?

Studies have established that the medicine's antihypertensive effectiveness is maintained for at least 24 hours with chronic daily use. Nonclinical toxicology research has also included long-term studies lasting up to two years to evaluate safety.


Q: Can Amlodipine cause digestive issues like constipation or diarrhea?

Gastrointestinal adverse effects that have been reported include constipation, diarrhea, and vomiting. These effects are generally rare, having been noted in post-marketing experience or in less than 1% of patients in clinical trials.


Q: Does Amlodipine affect sleep or cause insomnia?

Somnolence (drowsiness) is listed as a common effect. Separately, insomnia (difficulty sleeping) is also listed as an adverse reaction that occurred rarely (less than 1%) in clinical trials.


Q: Is Amlodipine suitable for people with asthma?

Official prescribing information does not list asthma as a contraindication or warning. This indicates that the medicine is not generally restricted for use solely because a person has this respiratory condition.


Q: What is the typical monitoring a doctor performs when prescribing Amlodipine?

Dosing instructions state that dosage is adjusted according to the patient's blood pressure goals and their response to the medicine. This implies that the primary form of monitoring is regular assessment of blood pressure.


Q: Does Amlodipine affect cholesterol levels?

While Amlodipine itself is not a cholesterol-lowering drug, official documents note a significant interaction with Simvastatin, a common cholesterol medicine. The recommended Simvastatin dose is limited when taken with Amlodipine due to increased Simvastatin exposure.


Q: Does Amlodipine affect sexual function?

Sexual dysfunction (for both male and female patients) is listed in official safety documents as a psychiatric adverse reaction. This effect was reported rarely, in less than 1% of patients in clinical trials.


Q: Can I take Amlodipine if I am pregnant or plan to be?

Official documentation states that use during pregnancy is restricted and only recommended when the potential benefit outweighs the potential risk to the fetus. Use during lactation is generally not recommended as the drug is known to be excreted in human milk.


Q: Can Amlodipine interact with over-the-counter cold and flu medications?

Specific cold and flu medicines are not universally named in the interaction list. Official patient information includes the statement that patients should report all medications, including non-prescription products, to a healthcare provider.


Q: Are there any dietary restrictions other than grapefruit when taking Amlodipine?

Official information confirms that Amlodipine may be taken with or without food as absorption is not affected by meals. The only specific food interaction noted in regulatory sources is with grapefruit or grapefruit juice.


Q: What are the most common reasons people stop taking Amlodipine?

Based on clinical trial data, the most commonly reported adverse reactions that may lead to discontinuation include edema (swelling), headache, fatigue, and dizziness. However, official data shows that discontinuation rates due to side effects are generally low.


Q: Does Amlodipine change how I feel emotionally?

Anxiety, depression, and abnormal dreams are listed in official safety documents as psychiatric adverse reactions. These emotional changes were reported rarely, occurring in less than 1% of patients in clinical trials.

Advertisements

How should Vasocard (Amlodipine) be stored and disposed of?

How to Store and Dispose of Vasocard (Amlodipine)?

The storage and disposal of Amlodipine tablets are governed by regulatory requirements to maintain product stability and ensure public safety.


Official Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, 20^circ to 25 C (68^circ to 77 F).
Protection Keep in the tight, light-resistant container it was dispensed in, protecting it from both light and moisture.
Child Safety The medicine must be kept out of the sight and reach of children.

Official Disposal Instructions

Expired or unused Amlodipine must be disposed of in accordance with local requirements. The preferred disposal method is often a drug take-back program. It is strictly mandated that the medicine must not be flushed down the toilet or emptied into drains to prevent environmental release.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Vasocard (Amlodipine) found in:

A-Z Index: